Tel: 972-2-6776705/6777673/6439575
Fax: 972-2-6421203
Mobile: 051874267
Email: chisin@hadassah.org.il
Personal
* Born January 31, 1947, Toulouse, France
* Married + 2
* Address: 14/4 Habanai Street, Jerusalem 96269
Curriculum Vitae
1971: MD, Faculté de Médecine et de Pharmacie de Toulouse, Université Paul Sabatier, France
1971-1973: Interne des Hôpitaux de Toulouse, Centre Hospitalo-Universitaire de Toulouse, France
1973-1974: Residency, Surgery, Hadassah Hebrew University Hospital, Jerusalem, Israel
1974-1978: Residency, ENT, Hadassah Hebrew University Hospital, Jerusalem, Israel
January 1979: Boards (Israeli Medical Association), ENT, Hadassah Hebrew University Hospital, Jerusalem, Israel
1982-1985: Residency, Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
October 1985: Boards (Israeli Medical Association), Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
August 1986-August 1988: NMR Research Fellow, MRI, MGH, Department of Radiology, Boston, MA, USA
February 1990-Dec. 1996: Acting Head, Dept. of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
January 1997-present: Head of Department of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
July 1993-February 1994: Special Volunteer, PET, NIH, Department of PET and Nuclear Medicine, Bethesda, Maryland, USA
August-October 1999: Visiting Professor, PET, Memorial Sloane-Kettering Cancer Center, Nuclear Medicine Service, New York, NY, USA
July 1993-Present: Associate Professor of Nuclear Medicine and Medical Biophysics, HU, Jerusalem, Israel
October 1982 - present: Senior Otorhinolaryngologist, ENT Department, Hadassah HU Hospital, Jerusalem (1/8 time activity), Israel
Immediate Past President of the Israeli Society of Nuclear Medicine (July 1999-July 2002).
Areas of Specialization
ENT
Head and Neck Imaging
Nuclear Psychiatry
Nuclear Oncology
Recent Publications (from 2000)
a. Head and Neck Imaging
Chisin R. and Macapinlac H.A. (2000) The Indications of FDG-PET in Neck Oncology. Radiological Clinics of North America, 38:999-1011.
Nunez R., Yeung H., and Chisin R. (2000) Fluorine-18 FDG Positron Emission Tomography in Advanced Nasopharyngeal Carcinoma. Clin. Nucl. Med., 25:731-733.
Krausz Y., Lebensart P.D., Klein M., Weininger J., Blachar A., Chisin R., Shiloni E. (2000) Pre-operative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease. World J. Surg., 24:1573-1578.
Ramos C.D., Chisin R., Yeung H.W.D., Larson S.M., Macapinlac H.A. (2001) Incidental focal thyroid uptake on FDG-PET scans should not be overlooked. Clin. Nucl. Med., 26:193-197.
Krausz Y , Shiloni E., Bocher M., Agranovicz S., Manos B., Chisin R. (2001) Diagnostic Dilemmas in Parathyroid Scintigraphy. Clin. Nucl. Med., 26:997-1001.
Krausz Y., Uziely B., Nesher R., Chisin R., Glaser B. (2001) Recombinant TSH in Differentiated Thyroid Cancer. IMAJ, 3:843-849.
b. PET and Nuclear Oncology
Klein M., Freedman N., Mishani E., Gimon Z., Lotem M., Chisin R. (2000) PET and lymphoscintigraphic evaluation of malignant melanomas. Nuklear Medizin, 39:56-61.
Siegal T., Rubinstein R., Bokstein F., Schwartz A., Lossos A., Shalom E., Chisin R., Gomori J.M. (2000) In vivo assessment of the window of barrier opening after osmotic blood-brain barrier description in humans, Journal of Neurosurgery, 92:599-605.
Rubinstein R., Broier R., Chisin R. (2001) The Contribution of FDG-PET to Diagnosis and Management of Lung Cancer - First Results. Harefuah, 140:100-103.
Klein M., Weininger J., Moshe S., Peretz T., Chisin R. (2001) The use of external radioactive markers in scintimammography. Clin. Nucl. Med., 26:10-13.
Nissan A., Spira R., Chisin R., Zamir O., Fros D., Klein M., Badirieh M., Freund H. (2001) Sentinel lymph node biopsy in breast cancer: a validation study and preliminary results. Harefuah, Journal of the Israel Medical Association, 140: 468-470.
Agid R., Rubinstein R., Siegal T., Lester H., Bokstein F., Chisin R., Gomori J.M. (2002) Does streaming affect the cerebral distribution of infra-ophtalmic intra-carotid chemotherapy? AJNR, 23:1732-1735.
c. PET and Nuclear Psychiatry
Bocher M., Chisin R., Parag Y., Freedman N., Meir Weil Y., Lester H., Mishani E., Bonne O. (2001) Cerebral activation associated with sexual arousal in response to a pornographic clip: A 15O-H2O PET study in heterosexual men. NeuroImage, 14:105-117.
Bonne O., Louzoun Y., Aharon I., Krausz Y., Karger H., Lerer B., Bocher M., Freedman N., and Chisin R. (2003) Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analyses. Psychiatry Research: Neuroimaging, 122(1):49-57.
Bonne, O., Gilboa, A., Louzoun, Y., Brandes, D., Yona, I.,Lester, H., Barkai, G., Freedman, N., Chisin, R., and Shalev, A. (2003) Resting Regional Cerebral Perfusion in Recent PTSD.Biological Psychiatry, In Press.
d. Radiochemistry
Mishani E., Bocher M., Ben David I., Rozen Y., Laki D., Marciano M., Chisin R. (2001) [C-11]Choline – automated preparation and clinical utilization. J. Labl. Comp. Radiopharm., 44S:379-381.
Bonasera T.A., Ortu G., Rozen Y., Krais R., Freedman N.M.T., Chisin R., Gazit A., Levitzki A., and Mishani E. (2001) Potential 18F-Labeled Biomarkers for Epidermal Growth Factor Receptor Tyrosine Kinase. J. of Nucl. Med. and Biol., 28(4):359-374.
Ortu G., Ben-David I., Rozen Y., Freedman N.M.T., Chisin R., Levitzki, A., Mishani E. (2002) In-vitro and In-vivo investigation of an irreversible labeled EGFr inhibitor (ML03) and its potential as PET biomarker in cancer and feasibility as an anticancer drug. Int. J. of Cancer, 101:360-370.
e. Innovative Technology
Bocher M., Balan A., Krausz Y., Shrem Y., Lonn A., WilkM., Chisin R. (2000) Gamma camera mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur. J. Nucl. Med., 27:619-627.
Akhurst T., and Chisin R. (2000) Hybrid PET/CT machines: optimized PET machines for the new millennium? Letter to the Editor. J. Nucl. Med., 41:961-962.
Ramos C.D., Erdi Y.E., Gonen M., Riedel E., Yeung H.W.D., Macapinlac H.A., Chisin R., Larson S.M. (2001) FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back projection. Eur. J. Nucl. Med., 28:155-164.
f. PET Cardiology and NMR Spectroscopy
Freedman N., Schechter D., Klein M., Marciano R., Rozenman Y., Chisin R. (2000) Retrospective Comparison between Rb-82 PET and Tl-201 SPECT Myocardial Perfusion Imaging: Insights into SPECT Attenuation Artifacts in Normal and Overweight Subjects. Clin. Nucl. Med., 25:1019-1023.
Olivson, A., Berman, E., Houminer, E., Borman, J.B., Merin, G., Karck, M., Haverich, A., Chisin, R., and Schwalb, H. (2002) Glucose Metabolism, Energetics, and Function of Rat Hearts Exposed to Ischemic Preconditioning and Oxygenated Cardioplegia. J. Card. Surg., 17:214-225.
g. Miscellaneous (Nuclear Medicine)
Bocher M., Shrem Y., Tappisser A., Klein M., Schechter D., Taylor JR A., Chisin R. (2001) Technetium-99m Mercaptoacetyltriglycin clearance: Comparison of camera-assisted methods. Clin. Nuc. Med., 26(9):745-750.
Sosna J., Chisin R., Klein M. (2002) FDG Positron Emission Tomographic Imaging of the Effect of an Intrauterine Device. Clin. Nuc. Med., 27:128-129.
Chisin, R. (2001) The role of various imaging modalities in diagnosing stress fractures. In Musculoskeletal Fatigue in Stress Fractures. Burr D. and Milgrom, C. Ed. CRC Press, pp. 279-294.
6. Teaching Areas
- Introduction to Nuclear Medicine and PET
- PET oncology
- Head and Neck Imaging
For more publications entrez PubMed